The Trump administration sees the increasing use of Chinese-made active ingredients in drugs taken by U.S. troops and civilians as a national security risk.
Contract price misalignment is among the leading causes of pricing issues in the healthcare supply chain. Price discrepancies are costing healthcare providers more than $92m annually.
The Trump administration cracked open the door for the eventual importation of cheaper medicines from abroad, the latest salvo in a battle to bring down drug costs.
The old days of the Quality movement seem quaint in retrospect: the banners, the slogans, the prizes and team-building events. Today, quality management is all about information — or, more to the point, how to keep from getting buried in it.
Entrepreneurship in the competitive cocaine market is evident from innovative distribution strategies that appear to reflect the type of disruption seen in other industries.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.